Key result
Monobody-based modulators (OP-2 and OP-4) successfully inhibited Adk tm kinase activity by capturing and stabilizing specific conformational states during large conformational changes.
Why the study?
It was unknown whether synthetic-binder-based strategies can regulate functions of proteins that undergo large conformational changes.
Monobody-based modulators can regulate the functions of proteins with large conformational changes by trapping specific conformational states.
Answers are grounded in this paper and cite their sources.
Monobodies modulate conformationally dynamic proteins; extends synthetic binder strategies but leaves clinical translation open.
Synthetic binding proteins have emerged as modulators of protein functions through protein–protein interactions (PPIs). Because PPIs are influenced by the structural dynamics of targeted proteins, investigating whether the synthetic‐binders‐based strategy is applicable for proteins with large conformational changes is important. This study demonstrates the applicability of monobodies (fibronectin type‐III domain‐based synthetic binding proteins) in regulating the functions of proteins that undergo tens‐of‐angstroms‐scale conformational changes, using an example of the A55C/C77S/V169C triple mutant (Adk tm ; a phosphoryl transfer‐catalyzing enzyme with a conformational change between OPEN/CLOSED forms). Phage display successfully developed monobodies that recognize the OPEN form (substrate‐unbound form), but not the CLOSED form of Adk tm . Two OPEN form‐specific clones (OP‐2 and OP‐4) inhibited Adk tm kinase activity. Epitope mapping with a yeast‐surface display/flow cytometry indicated that OP‐2 binds to the substrate‐entry side of Adk tm , whereas OP‐4 binding occurs at another site. Small angle X‐ray scattering coupled with size‐exclusion chromatography (SEC‐SAXS) indicated that OP‐4 binds to the hinge side opposite to the substrate‐binding site of Adk tm , retaining the whole OPEN‐form structure of Adk tm . Titration of the OP‐4–Adk tm complex with Ap 5 A, a transition‐state analog of Adk tm , showed that the conformational shift to the CLOSED form was suppressed although Adk tm retained the OPEN‐form (i.e., substrate‐binding ready form). These results show that OP‐4 captures and stabilizes the OPEN‐form state, thereby affecting the hinge motion. These experimental results indicate that monobody‐based modulators can regulate the functions of proteins that show tens‐of‐angstroms‐scale conformational changes, by trapping specific conformational states generated during large conformational change process that is essential for function exertion.
No takes yet. Share an insight, caveat, or question.
Nakamura et al. (2023) studied this question. Monobodies (OP-2 and OP-4) was evaluated on Inhibition of Adk tm kinase activity and conformational trapping. Monobody-based modulators (OP-2 and OP-4) successfully inhibited Adk tm kinase activity by capturing and stabilizing specific conformational states during large conformational changes.
Synapse has enriched 10 related papers. Consider them for comparative context: